REFERENCES
- Aiedeh K., Giannsi E., Orienti I., Zecchi V. Chitosan microcapsules as controlled release systems for insulin. J. Microencaps. 1997; 14: 567–576
- Anal A. K., Stevens W. F. Chitosan-alginate multilayer beads for controlled release of ampicillin. Int. J. Pharm. 2005; 290: 45–54
- Aral C., Akbuga J. Alternative approach to the preparation of chitosan beads. Int. J. Pharm. 1998; 168: 9–17
- Becheran-Maron L., Peniche C., Arguelles-Monal W. Study of the inter-polyelectrolyte reaction between chitosan and alginate: influence of alginate composition and chitosan molecular weight. Int. J. Biol. Macromol. 2004; 34: 127–133
- Binkley C. E., Cinti S., Simeone D. M., Colletti L. M. Bacillus anthracis as an agent of bioterrorism: a review emphasizing surgical treatment. Ann. Surg. 2002; 236: 9–16
- Blondeau J. M. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Drugs 2004; 64: 611–628
- Bodmeier R., Chen H., Tyle P., Jarosz P. Pseudoephedrine HCl microspheres formulated into an oral suspension dosage form. J. Contr. Rel. 1991; 15: 65–77
- Bodmeier R., Oh K. H., Parmar Y. Preparation and evaluation of drug containing chitosan beads. Drug Dev. Ind. Pharm. 1989; 15: 1475–1494
- Higuchi T. Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963; 52: 1145–1149
- Knutson D., Greenberg G., Cronau H. Management of Chron's disease—a practical approach. Am. Fam. Physician. 2003; 68: 707–714
- Ko J. A., Park H. J., Hwang S. J., Park J. B., Lee J. S. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int. J. Pharm. 2002; 249: 165–174
- Korsmeyer R. W., Gurny R., Doelker E. M., Buri P., Peppas N. A. Mechanism of solute release from porous hydrophilic matrices. Int. J. Pharm. 1983; 15: 25–35
- Lin Y. H., Liang H. F., Chung C. K., Chen M. C., Sung H. W. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 2005; 26: 2105–2113
- Mitrevej A., Sinchaipanid N., Rungvejahvuttivittaya Y., Kositchaiyong V. Multiunit controlled release diclofenac sodium capsules using complex of chitosan with sodium alginate or pectin. Pharm. Dev. Tech. 2000; 6: 385–392
- Murata Y., Kontani Y., Ohmae H., Kawashima S. Behaviour of alginate gel beads containing chitosan salt prepared with water-soluble vitamins. Eur. J. Pharm. Biopharm. 2002; 53: 249–251
- Orienti I., Cerchiara T., Luppi B., Bigucci F., Zuccari G., Zecchi V. Influence of different chitosan salts on the release of sodium diclofenac in colon-specific delivery. Int. J. Pharm. 2002; 238: 51–59
- Pasparaski G., Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int. J. Pharm. 2006; 323: 34–42
- Peppas N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta. Helv. 1985; 60: 110–111
- Pile J. C., Malone D., Eitzen E. M., Friedlander A. M. Anthrax as a potential biological warfare agent. Arch. Int. Med. 1998; 158: 429–434
- Reza S., Quadir M. A., Haider S. S. Comparative evaluation of plastic, hydrophobic, and hydrophilic polymers as matrices for controlled release drug delivery. J. Pharm. Pharmceut. Sci. 2003; 6: 282–291
- Riberio A. J., Silva C., Ferreira D., Veiga F. Chitosan reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur. J. Pharm. Sci. 2005; 25: 31–40
- Roberts G. A. F. Solubility and solution behavior of chitin and chitosan. Chitin chemistry, G. A. F. Roberts. MacMIllan, Houndmills 1992; 274–329
- Sezer A. D., Akbuga J. Release characteristics of chitosan treated alginate beads: II. Sustained release of a low molecular drug from chitosan treated alginate beads. J. Microencaps 1999; 16: 687–696
- Sheu M. T., Chou H. L., Kao C. C., Liu C. H., Sokolski T. D. Dissolution of diclofenac sodium from matrix tablet. Int. J. Pharm. 1992; 85: 57–63
- Shiraishi S., Imai T., Otagiri M. Controlled release of indomethacin by chitosan-polyelectrolyte complex: Optimization and in vivo/ in vitro evaluation. J. Contr. Rel. 1993; 25: 217–225
- Shu X. Z., Zhu K. J. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int. J. Pharm. 2000; 201: 51–58
- Struszczyk H., Wawro D., Niekraszewicz A. Biodegradability of chitosan fibres. Advances in Chitin and Chitosan, C. J. Brine, P. A. Sandford, J. P. Zikakis. Elsevier Applied Sciences, London 1991; 580–585
- Takahashi T., Takayama T., Machida Y., Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and polyacrylate. Int. J. Pharm. 1990; 61: 35–41
- Xu Y., Zhan C., Fan L., Wang L., Zheng H. Preparation of dual crosslinked alginate-chitosan blend gel blend and in vitro release in oral site-specific drug delivery system. Int. J. Pharm. 2007; 336: 329–337
- Yalpani M., Hall L. D. Some chemical and analytical aspects of polysaccharide modification. 3. Formation of branched-chain, soluble chitosan derivatives. Macromolecules 1984; 17: 272–279